dMed Global, now operating as Caidya, is a global, full-service clinical research organization (CRO) headquartered in Shanghai, China and backed by Qiming Venture Partners. The company provides flexible, patient-centric clinical trial solutions to biopharmaceutical innovators, running studies across more than 40 countries and regions. - View it on GitHub